Singapore markets close in 3 hours 7 minutes
Straits Times Index
3,324.24 +10.10 (+0.30%) Nikkei
39,153.49 +348.84 (+0.90%) Hang Seng
18,131.18 +103.47 (+0.57%) FTSE 100
8,281.55 +43.83 (+0.53%) Bitcoin USD
60,984.66 -1,336.82 (-2.15%) CMC Crypto 200
1,272.18 -37.54 (-2.87%)
Pieris Pharmaceuticals Inc (PI6.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
| Previous close | 10.58 |
| Open | 0.13 |
| Bid | 0.14 x 520000 |
| Ask | 0.14 x 520000 |
| Day's range | 0.13 - 10.58 |
| 52-week range | 0.13 - 68.40 |
| Volume | |
| Avg. volume | 16 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 29 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Investors Don't See Light At End Of Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Tunnel And Push Stock Down 27%
To the annoyance of some shareholders, Pieris Pharmaceuticals, Inc. ( NASDAQ:PIRS ) shares are down a considerable 27...
ZacksPieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's Why
Pieris Pharmaceuticals (PIRS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ZacksPieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's What You Should Know
Pieris Pharmaceuticals (PIRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
© 2024 Yahoo. All rights reserved.